3/11/2023 0 Comments Keymo rhearpoyMahdi J, Goyal MS, Griffith J, Morris SM, Gutmann DH. Increased prevalence of brain tumors classified as T2 hyperintensities in neurofibromatosis 1. Griffith JL, Morris SM, Mahdi J, Goyal MS, Hershey T, Gutmann DH. The use of magnetic resonance imaging screening for optic pathway gliomas in children with neurofibromatosis type 1. Biochemical diagnosis of pheochromocytoma: which test is best?. Pheochromocytoma: an update on genetics and management. Karagiannis A, Mikhailidis DP, Athyros VG, et al. The diagnostic and clinical significance of café-au-lait macules. SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype. Spurlock G, Bennett E, Chuzhanova N, Thomas N, Jim HP, Side L. Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use. 61:189-98.īettegowda C, Upadhayaya M, Evans DG, Kim A, Mathios D, Hanemann CO, et al. Optic pathway gliomas in neurofibromatosis-1: Controversies and recommendations. Listernick R, Ferner RE, Liu, GT, Gutmann DH. Sex is a major determinant of neuronal dysfunction in neurofibromatosis type 1. Coronary arterial aneurysms in neurofibromatosis 1: case report and review of the literature. Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1). Tucker T, Schnabel C, Hartmann M, Friedrich RE, Frieling I, Kruse HP. High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1. Seitz S, Schnabel C, Busse B, Schmidt HU, Beil FT, Friedrich RE, et al. Evidence of increased bone resorption in neurofibromatosis type 1 using urinary pyridinium crosslink analysis. Stevenson DA, Schwarz EL, Viskochil DH, et al. Generalized metabolic bone disease in Neurofibromatosis type I. 2013 Nov 4.īrunetti-Pierri N, Doty SB, Hicks J, et al. Neurofibromatosis Type 1 and Autism Spectrum Disorder. Garg S, Green J, Leadbitter K, Emsley R, Lehtonen A, Evans DG, et al. Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q. Yamamoto H, Tobo T, Nakamori M, Imamura M, Kojima A, Oda Y. Malignant myoepithelioma arising in adenomyoepithelioma of the breast and coincident multiple gastrointestinal stromal tumours in a patient with neurofibromatosis type 1. Hegyi L, Thway K, Newton R, Osin P, Nerurkar A, Hayes AJ. Gastrointestinal and Retroperitoneal Manifestations of Type 1 Neurofibromatosis. 2009:756395.īasile U, Cavallaro G, Polistena A, Giustini S, Orlando G, Cotesta D. Survival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated Tumours. Porter DE, Prasad V, Foster L, Dall GF, Birch R, Grimer RJ. Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients. Rodriguez FJ, Perry A, Gutmann DH, et al. Prevalence of plexiform neurofibroma in children and adolescents with type I neurofibromatosis. 66(1):7-10.ĭarrigo LG Jr, Geller M, Bonalumi Filho A, et al. Life expectancy in hereditary cancer predisposing diseases: an observational study. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Legius E, Messiaen L, Wolkenstein P, et al.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |